| 000 | 01170 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514045412.0 | ||
| 264 | 0 | _c20021122 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0300-0664 | ||
| 024 | 7 |
_a10.1046/j.1365-2265.2002.01619.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarcía de la Torre, N | |
| 245 | 0 | 0 |
_aAntiangiogenic effects of somatostatin analogues. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cOct 2002 |
||
| 300 |
_a425-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
| 650 | 0 | 4 |
_aEndocrine Gland Neoplasms _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aRetinal Neovascularization _xdrug therapy |
| 650 | 0 | 4 |
_aSomatostatin _xanalogs & derivatives |
| 700 | 1 | _aWass, J A H | |
| 700 | 1 | _aTurner, H E | |
| 773 | 0 |
_tClinical endocrinology _gvol. 57 _gno. 4 _gp. 425-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2265.2002.01619.x _zAvailable from publisher's website |
| 999 |
_c12166557 _d12166557 |
||